Details checkedStatus confirmedCheckedregulatory

Sophono Alpha 2 MPO System

Also known as: Alpha 2 MPO, Sophono Alpha 2, Medtronic Sophono Alpha 2 MPO ePlus, Alpha 2 MPO ePlus

Medtronic

Primary source

Company

Medtronic

Program Type

Device

Modality

Bone Conduction / Middle-Ear Device

Stage

Marketed

Status

Marketed

Target Gene

—

Route / Mode

Passive transcutaneous magnetic bone-conduction implant and external processor

Confidence

88%

Status Confidence

Status confirmed

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

United States, Europe, India, Global

Population

adult, pediatric, bone-conduction-implant, transcutaneous-implant, single-sided-deafness

Trial IDs

Mechanism

Magnetic transcutaneous bone-conduction hearing system using implanted magnets and an external Alpha sound processor to transmit vibrations through intact skin to the cochlea.

Indications

Hearing Loss Conductive Hearing Loss Mixed Hearing Loss Single-Sided Deafness

Notes

Adds the magnetic passive transcutaneous Sophono/Alpha lineage, which is distinct from percutaneous Ponto/Baha and active transcutaneous Osia/BONEBRIDGE/Sentio systems. U.S. support/ownership has changed, but product-family relevance remains clear.

Evidence & Sources

3 structured sources

company

Supports: canonicalName, company, mechanism, status, route, populationTags

Open

regulatory

Supports: indications, stage, geography

IDs: K112053

Open

company

Supports: allCompanies, notes

Open